Correction
Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma
Paper Information
Record ID:
53726
Author(s):
Publication Date:
June 03, 2021
Retraction Date:
October 31, 2022
(3.1 years years ago)
Subjects:
Institution:
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USACountry:
🇺🇸 United StatesArticle Type:
Publisher:
MDPI
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (9)
9
Total Citations5
Post-Retraction(55.6%)
2
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
562
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780
Kavitha Godugu, Mehdi Rajabi, Shaker A. Mousa
Cancers
Open Access
Published: May 2024
1 citation
1 citation
562 days after retraction
Potential Anticancer Activity of Novel Triazoles and Related Derivatives
José Aguirre-de Paz, Nancy Lara‐Almazán, Alejandra Ancira-Cortez et al. (4 authors)
Interdisciplinary cancer research
Published: Jan 2024
1 citation
1 citation
427 days after retraction
The thyroid endocrine axis in breast cancer pathophysiology and prognosis
Ioannis A. Voutsadakis
Vitamins and hormones
Published: Jan 2024
427 days after retraction
Preclinical assessment of drug–drug interaction of <scp>fb‐PMT</scp>, a novel anti‐cancer thyrointegrin αvβ3 antagonist
Kazutoshi Fujioka, Mostafa I. Fekry, Jeanne M. Rumsey et al. (6 authors)
Clinical and Translational Science
Open Access
Published: Mar 2023
3 citations
3 citations
147 days after retraction
Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review
Shijia Zhao, Jie Liu, Zaosheng Lv et al. (5 authors)
European Journal of Medicinal Chemistry
Published: Mar 2023
58 citations
58 citations
126 days after retraction
Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780
Kavitha Godugu, Mehdi Rajabi, Shaker A. Mousa
Cancers
Open Access
Published: Oct 2022
1 citation
1 citation
Same day as retraction
The Role of Graphene Oxide Nanocarriers in Treating Gliomas
Bin Wang, Hanfei Guo, Haiyang Xu et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Jan 2022
21 citations
21 citations
276 days before retraction
Novel Treatment Strategies for Glioblastoma—A Summary
Stanley S. Stylli
Cancers
Open Access
Published: Nov 2021
10 citations
10 citations
343 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #53721
May 15, 2024Quick Stats
Total Citations:
13
Years Since Retraction:
3.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025